search
Back to results

The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption

Primary Purpose

Alcohol Drinking

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Beer 5%o
Beer 8.5%o and water
Beer 8.5%o and stock
Water
Sponsored by
University Hospital, Basel, Switzerland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Alcohol Drinking focused on measuring Copeptin, Salt-water homeostasis

Eligibility Criteria

20 Years - 40 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy males

Exclusion Criteria:

  • Any acute or chronic illness
  • History of alcohol dependency
  • Alcohol consumption >2 units/day
  • Active nicotine abuse
  • Gluten intolerance
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc. of the participant
  • Participation in another study with investigational drug within the 30 days preceding and during the present study
  • Enrolment of the investigator, his/her family members, employees and other dependent persons
  • Epileptic seizures within the last year
  • BMI <18.5 or ≥25.9kg/m2

Sites / Locations

  • University Hospital Basel

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Active Comparator

Active Comparator

Placebo Comparator

Arm Label

Beer alone

Beer and water

Beer and stock

Water alone

Arm Description

Consumption of beer (correlated for weight to reach a blood alcohol concentration of 0.8) during 1 hour. Continues measurement of sodium, osmolality, copeptin, urinary sodium, urinary osmolality over 12 hours.

Consumption of beer and additional water (correlated for weight to reach a blood alcohol concentration of 0.8, 1/3 of water, 2/3 of beer) during 1 hour. Continues measurement of sodium, osmolality, copeptin, urinary sodium, urinary osmolality over 12 hours.

Consumption of beer and additional stock(correlated for weight to reach a blood alcohol concentration of 0.8, 1/3 of stock, 2/3 of beer) during 1 hour. Continues measurement of sodium, osmolality, copeptin, urinary sodium, urinary osmolality over 12 hours.

Consumption of water alone (correlated for weight to reach a blood alcohol concentration of 0.8, 1/3 of stock, 2/3 of beer) during 1 hour. Continues measurement of sodium, osmolality, copeptin, urinary sodium, urinary osmolality over 12 hours.

Outcomes

Primary Outcome Measures

Difference in copeptin levels between the interventions
Difference in copeptin levels (pmol/l) between moderate beer consumption and moderate beer consumption with additional water and sodium (stock/bouillon) intake at timepoint 1.5 hours.

Secondary Outcome Measures

Change in copeptin levels between the interventions throughout the observation period of 12 hours
Change in copeptin Levels (pmol/l) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the Intervention, comparing the interventions
Change in plasma sodium levels between the interventions throughout the observation period of 12 hours
Change in plasma sodium (mmol/l) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in urinary sodium levels between the interventions throughout the observation period of 12 hours
Change in urinary sodium (mmol/kg) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in plasma osmolality levels between the interventions throughout the observation period of 12 hours
Change in plasma osmolality (mmol/kg) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in urinary osmolality levels between the interventions throughout the observation period of 12 hours
Change in urinary osmolality (mmol/kg) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in plasma Glucose levels between the interventions throughout the observation period of 12 hours
Change in plasma glucose (mmol/l) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in biomarkers involved in the sodium-water homeostasis between the interventions throughout the observation period of 12 hours
Change in different biomarkers (e.g., Fibroblast growth factor 21, aldosterone, renin, Interleukin 6, Interleukin 8) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Difference in urinary excretion between the interventions throughout the observation period of 12 hours
Amount of total urinary excretion (ml) at time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours and 12 hours after start of the intervention, comparing the interventions
Change in blood alcohol content between the interventions throughout the observation period of 12 hours
Change in blood alcohol content (°/oo) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours and 12 hours after start of the intervention, comparing the interventions
Difference in Response to lottery Experiment before and after the intervention
Change in decision making before and after the intervention, comparing the interventions

Full Information

First Posted
March 13, 2019
Last Updated
May 14, 2019
Sponsor
University Hospital, Basel, Switzerland
search

1. Study Identification

Unique Protocol Identification Number
NCT03883503
Brief Title
The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption
Official Title
The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption - a Pathophysiological Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2019
Overall Recruitment Status
Completed
Study Start Date
February 25, 2019 (Actual)
Primary Completion Date
April 10, 2019 (Actual)
Study Completion Date
April 10, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Basel, Switzerland

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The main interest of this study is to investigate the influence of moderate alcohol consumption (beer) on salt-water homeostasis. Therefore, 10 healthy volunteers will participate in 4 Intervention: Beer alone Beer and water Beer and salt (stock/bouillon) Water alone During the study day, copeptin, sodium, osmolality and urinary sodium/osmolality will be measured at 6 timepoints.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcohol Drinking
Keywords
Copeptin, Salt-water homeostasis

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Beer alone
Arm Type
Experimental
Arm Description
Consumption of beer (correlated for weight to reach a blood alcohol concentration of 0.8) during 1 hour. Continues measurement of sodium, osmolality, copeptin, urinary sodium, urinary osmolality over 12 hours.
Arm Title
Beer and water
Arm Type
Active Comparator
Arm Description
Consumption of beer and additional water (correlated for weight to reach a blood alcohol concentration of 0.8, 1/3 of water, 2/3 of beer) during 1 hour. Continues measurement of sodium, osmolality, copeptin, urinary sodium, urinary osmolality over 12 hours.
Arm Title
Beer and stock
Arm Type
Active Comparator
Arm Description
Consumption of beer and additional stock(correlated for weight to reach a blood alcohol concentration of 0.8, 1/3 of stock, 2/3 of beer) during 1 hour. Continues measurement of sodium, osmolality, copeptin, urinary sodium, urinary osmolality over 12 hours.
Arm Title
Water alone
Arm Type
Placebo Comparator
Arm Description
Consumption of water alone (correlated for weight to reach a blood alcohol concentration of 0.8, 1/3 of stock, 2/3 of beer) during 1 hour. Continues measurement of sodium, osmolality, copeptin, urinary sodium, urinary osmolality over 12 hours.
Intervention Type
Other
Intervention Name(s)
Beer 5%o
Intervention Description
Weight adjusted beer to reach 0.8 blood alcohol content will be given over the time course of 1 hour to the participants
Intervention Type
Other
Intervention Name(s)
Beer 8.5%o and water
Intervention Description
Weight adjusted beer to reach 0.8 blood alcohol content and water will be given over the time course of 1 hour to the participants
Intervention Type
Other
Intervention Name(s)
Beer 8.5%o and stock
Intervention Description
Weight adjusted beer to reach 0.8 blood alcohol content and stock will be given over the time course of 1 hour to the participants
Intervention Type
Other
Intervention Name(s)
Water
Intervention Description
Water equivalent to the calculated volume of beer will be given over the time course of 1 hour to the participants
Primary Outcome Measure Information:
Title
Difference in copeptin levels between the interventions
Description
Difference in copeptin levels (pmol/l) between moderate beer consumption and moderate beer consumption with additional water and sodium (stock/bouillon) intake at timepoint 1.5 hours.
Time Frame
30 minutes after intervention
Secondary Outcome Measure Information:
Title
Change in copeptin levels between the interventions throughout the observation period of 12 hours
Description
Change in copeptin Levels (pmol/l) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the Intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Change in plasma sodium levels between the interventions throughout the observation period of 12 hours
Description
Change in plasma sodium (mmol/l) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Change in urinary sodium levels between the interventions throughout the observation period of 12 hours
Description
Change in urinary sodium (mmol/kg) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Change in plasma osmolality levels between the interventions throughout the observation period of 12 hours
Description
Change in plasma osmolality (mmol/kg) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Change in urinary osmolality levels between the interventions throughout the observation period of 12 hours
Description
Change in urinary osmolality (mmol/kg) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Change in plasma Glucose levels between the interventions throughout the observation period of 12 hours
Description
Change in plasma glucose (mmol/l) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Change in biomarkers involved in the sodium-water homeostasis between the interventions throughout the observation period of 12 hours
Description
Change in different biomarkers (e.g., Fibroblast growth factor 21, aldosterone, renin, Interleukin 6, Interleukin 8) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Difference in urinary excretion between the interventions throughout the observation period of 12 hours
Description
Amount of total urinary excretion (ml) at time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours and 12 hours after start of the intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Change in blood alcohol content between the interventions throughout the observation period of 12 hours
Description
Change in blood alcohol content (°/oo) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours and 12 hours after start of the intervention, comparing the interventions
Time Frame
Observation period of 12 hours
Title
Difference in Response to lottery Experiment before and after the intervention
Description
Change in decision making before and after the intervention, comparing the interventions
Time Frame
Directly before and 30 minutes after intervention

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy males Exclusion Criteria: Any acute or chronic illness History of alcohol dependency Alcohol consumption >2 units/day Active nicotine abuse Gluten intolerance Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc. of the participant Participation in another study with investigational drug within the 30 days preceding and during the present study Enrolment of the investigator, his/her family members, employees and other dependent persons Epileptic seizures within the last year BMI <18.5 or ≥25.9kg/m2
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mirjam Christ-Crain, Prof. Dr. MD
Organizational Affiliation
University Hospital, Basel, Switzerland
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Basel
City
Basel
ZIP/Postal Code
4031
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption

We'll reach out to this number within 24 hrs